Association of Extubation Failure Rates With High-Flow Nasal Cannula, Continuous Positive Airway Pressure, and Bilevel Positive Airway Pressure vs Conventional Oxygen Therapy in Infants and Young Children: A Systematic Review and Network Meta-Analysis.
Journal
JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
8
8
2023
pubmed:
5
6
2023
entrez:
5
6
2023
Statut:
ppublish
Résumé
Extubation failure (EF) has been associated with worse outcomes in critically ill children. The relative efficacy of different modes of noninvasive respiratory support (NRS) to prevent EF is unknown. To study the reported relative efficacy of different modes of NRS (high-flow nasal cannula [HFNC], continuous positive airway pressure [CPAP], and bilevel positive airway pressure [BiPAP]) compared to conventional oxygen therapy (COT). MEDLINE, Embase, and CINAHL Complete through May 2022. Randomized clinical trials that enrolled critically ill children receiving invasive mechanical ventilation for more than 24 hours and compared the efficacy of different modes of postextubation NRS. Random-effects models were fit using a bayesian network meta-analysis framework. Between-group comparisons were estimated using odds ratios (ORs) or mean differences with 95% credible intervals (CrIs). Treatment rankings were assessed by rank probabilities and the surface under the cumulative rank curve (SUCRA). The primary outcome was EF (reintubation within 48 to 72 hours). Secondary outcomes were treatment failure (TF, reintubation plus NRS escalation or crossover to another NRS mode), pediatric intensive care unit (PICU) mortality, PICU and hospital length of stay, abdominal distension, and nasal injury. A total of 11 615 citations were screened, and 9 randomized clinical trials with a total of 1421 participants were included. Both CPAP and HFNC were found to be more effective than COT in reducing EF and TF (CPAP: OR for EF, 0.43; 95% CrI, 0.17-1.0 and OR for TF 0.27, 95% CrI 0.11-0.57 and HFNC: OR for EF, 0.64; 95% CrI, 0.24-1.0 and OR for TF, 0.34; 95% CrI, 0.16- 0.65). CPAP had the highest likelihood of being the best intervention for both EF (SUCRA, 0.83) and TF (SUCRA, 0.91). Although not statistically significant, BiPAP was likely to be better than COT for preventing both EF and TF. Compared to COT, CPAP and BiPAP were reported as showing a modest increase (approximately 3%) in nasal injury and abdominal distension. The studies included in this systematic review and network meta-analysis found that compared with COT, EF and TF rates were lower with modest increases in abdominal distension and nasal injury. Of the modes evaluated, CPAP was associated with the lowest rates of EF and TF.
Identifiants
pubmed: 37273226
pii: 2805373
doi: 10.1001/jamapediatrics.2023.1478
pmc: PMC10242512
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
774-781Subventions
Organisme : NICHD NIH HHS
ID : R13 HD102137
Pays : United States
Références
Sci Rep. 2020 Jan 22;10(1):937
pubmed: 31969674
J Clin Epidemiol. 2019 Apr;108:77-85
pubmed: 30529648
Res Synth Methods. 2019 Dec;10(4):569-581
pubmed: 31349391
South Afr J Crit Care. 2022 May 06;38(1):
pubmed: 35784000
Respir Care. 2022 Apr;67(4):448-454
pubmed: 35260472
Intensive Care Med. 2022 Feb;48(2):137-147
pubmed: 34825256
Arch Bronconeumol. 2002 Oct;38(10):463-7
pubmed: 12372195
Pediatr Crit Care Med. 2020 Sep;21(9):e672-e678
pubmed: 32433439
Arch Dis Child Fetal Neonatal Ed. 2019 Jan;104(1):F8-F12
pubmed: 30425115
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):456-61
pubmed: 24912486
Chest. 2023 May;163(5):1130-1143
pubmed: 36563873
JAMA. 2014 Jul;312(2):171-9
pubmed: 25005654
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Med Decis Making. 2013 Jul;33(5):618-40
pubmed: 23804507
JAMA. 2022 Mar 1;327(9):836-845
pubmed: 35230393
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
Turk J Pediatr. 2018;60(2):126-133
pubmed: 30325117
Crit Care. 2018 Jun 4;22(1):144
pubmed: 29866165
J Clin Epidemiol. 2011 Feb;64(2):163-71
pubmed: 20688472
JAMA. 2022 Jul 12;328(2):162-172
pubmed: 35707984
Pediatr Crit Care Med. 2005 May;6(3):312-8
pubmed: 15857531
Res Synth Methods. 2012 Dec;3(4):285-99
pubmed: 26053422
Intern Med J. 2020 Nov;50(11):1390-1396
pubmed: 31908096
Am J Respir Crit Care Med. 2023 Jan 1;207(1):17-28
pubmed: 36583619
Pediatr Crit Care Med. 2015 Feb;16(2):124-30
pubmed: 25560423
Crit Care Med. 2017 Aug;45(8):e798-e805
pubmed: 28437378
JAMA. 2022 Apr 26;327(16):1550-1552
pubmed: 35390115
Syst Rev. 2017 Apr 12;6(1):79
pubmed: 28403893
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Mar;53(2):321-326
pubmed: 35332737
J Clin Epidemiol. 2018 Jan;93:36-44
pubmed: 29051107
Crit Care Med. 2003 Nov;31(11):2657-64
pubmed: 14605539
Evid Based Med. 2016 Aug;21(4):125-7
pubmed: 27339128
BMJ. 2011 Jan 11;342:c7086
pubmed: 21224324